drugset / Trial / NCT02585869
Efficacy and Safety of Gemcabene in Patients With Low HDL-C and Either Normal or Elevated Triglycerides
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the effect of gemcabene on HDL-C, LDL-C, TG, and other lipid levels in patients with low HDL-C
Timeline
- Start
- 1999-12
- Primary completion
- 2001-06
- Completion
- 2001-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcabene | Small molecule | 150 mg | — |
| Subject | Gemcabene | Small molecule | 300 mg | — |
| Subject | Gemcabene | Small molecule | 600 mg | — |
| Subject | Gemcabene | Small molecule | 900 mg | — |